These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 25193670

  • 1. Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Piccolo R, Galasso G, Iversen AZ, Eitel I, Dominguez-Rodriguez A, Gu YL, de Smet BJ, Mahmoud KD, Abreu-Gonzalez P, Trimarco B, Thiele H, Piscione F.
    Am J Cardiol; 2014 Oct 15; 114(8):1145-50. PubMed ID: 25193670
    [Abstract] [Full Text] [Related]

  • 2. Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention.
    Perkan A, Vitrella G, Barbati G, De Monte A, D'Agata B, Merlo M, Giannini F, Della Grazia E, Rakar S, Salvi A, Igidbashian D, Morgera T, Zalukar W, Sinagra G.
    J Cardiovasc Med (Hagerstown); 2013 Feb 15; 14(2):127-35. PubMed ID: 22343257
    [Abstract] [Full Text] [Related]

  • 3. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.
    Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW.
    Am Heart J; 2013 Jul 15; 166(1):64-70. PubMed ID: 23816023
    [Abstract] [Full Text] [Related]

  • 4. Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Piccolo R, Eitel I, Galasso G, Iversen AZ, Gu YL, Dominguez-Rodriguez A, de Smet BJ, Mahmoud KD, Abreu-Gonzalez P, Thiele H, Piscione F.
    Vascul Pharmacol; 2015 Oct 15; 73():32-7. PubMed ID: 26071862
    [Abstract] [Full Text] [Related]

  • 5. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, van den Heuvel AF, Tan ES, Pundziute G, van der Werf R, Hoseyni Guyomi S, van der Horst IC, Zijlstra F, de Smet BJ.
    Circulation; 2010 Dec 21; 122(25):2709-17. PubMed ID: 21098442
    [Abstract] [Full Text] [Related]

  • 6. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.
    Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, Mielecki W, Depukat R, Janzon M, Stefaniak J, Zmudka K, Dubiel JS, Partyka L, Dudek D.
    Am Heart J; 2009 Oct 21; 158(4):569-75. PubMed ID: 19781416
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G.
    Circulation; 2008 Jul 01; 118(1):49-57. PubMed ID: 18559698
    [Abstract] [Full Text] [Related]

  • 11. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry).
    Dziewierz A, Mielecki W, Siudak Z, Rakowski T, Janzon M, Birkemeyer R, Zasada W, Dubiel JS, Dudek D.
    Atherosclerosis; 2012 Jul 01; 223(1):212-8. PubMed ID: 22658254
    [Abstract] [Full Text] [Related]

  • 12. Effect of Pericardial Effusion Complicating ST-Elevation Myocardial Infarction as Predictor of Extensive Myocardial Damage and Prognosis.
    Jobs A, Eitel C, Pöss J, Desch S, Thiele H, Eitel I.
    Am J Cardiol; 2015 Oct 01; 116(7):1010-6. PubMed ID: 26235929
    [Abstract] [Full Text] [Related]

  • 13. Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction.
    Piccolo R, Galasso G, Eitel I, Dominguez-Rodriguez A, Iversen AZ, Gu YL, Abreu-Gonzalez P, de Smet BJ, Esposito G, Windecker S, Thiele H, Piscione F.
    Am J Cardiol; 2016 Dec 15; 118(12):1798-1804. PubMed ID: 27756477
    [Abstract] [Full Text] [Related]

  • 14. Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials.
    De Luca G, Verdoia M, Suryapranata H.
    Atherosclerosis; 2012 Jun 15; 222(2):426-33. PubMed ID: 22483166
    [Abstract] [Full Text] [Related]

  • 15. Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shimada YJ, Nakra NC, Fox JT, Kanei Y.
    Am J Cardiol; 2012 Mar 01; 109(5):624-8. PubMed ID: 22152971
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of early versus late glycoprotein IIb/IIIa inhibitors for PCI.
    Xu Q, Yin J, Si LY.
    Int J Cardiol; 2013 Jan 20; 162(3):210-9. PubMed ID: 22769575
    [Abstract] [Full Text] [Related]

  • 17. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK, Liem SS, van der Kley F, Bergheanu SC, Wolterbeek R, Bosch J, Bootsma M, Zeppenfeld K, van der Laarse A, Atsma DE, Jukema JW, Schalij MJ.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):335-43. PubMed ID: 19642182
    [Abstract] [Full Text] [Related]

  • 18. Factors Associated With Infarct-Related Artery Patency Before Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the FAST-MI 2010 Registry).
    Bailleul C, Puymirat E, Aissaoui N, Schiele F, Ducrocq G, Coste P, Blanchard D, Brasselet C, Elbaz M, Steg PG, Le Breton H, Bonnefoy-Cudraz E, Montalescot G, Cottin Y, Goldstein P, Ferrières J, Simon T, Danchin N, FAST-MI Investigators.
    Am J Cardiol; 2016 Jan 01; 117(1):17-21. PubMed ID: 26541905
    [Abstract] [Full Text] [Related]

  • 19. Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year.
    Iversen AZ, Galatius S, Abildgaard U, Galloe A, Hansen PR, Pedersen S, Engstroem T, Jensen JS.
    Cardiology; 2011 Jan 01; 120(1):43-9. PubMed ID: 22122887
    [Abstract] [Full Text] [Related]

  • 20. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Estévez-Loureiro R, Salgado-Fernández J, Marzoa-Rivas R, Barge-Caballero E, Pérez-Pérez A, Noriega-Concepción V, Calviño-Santos R, Vázquez-Rodríguez JM, Vázquez-González N, Castro-Beiras A, Kaski JC.
    Thromb Res; 2009 Nov 01; 124(5):536-40. PubMed ID: 19467699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.